Key Takeaways
- P&G Acquires Thorne for $3.8 Billion: Procter & Gamble makes a massive bet on personalized nutrition, expanding its footprint in the vitamins, minerals, and supplements category.
- Kirin Holdings Acquires Jamieson Wellness: Japan's Kirin continues its global expansion by purchasing Canada's leading supplement brand for C$2.5 billion.
- Bipartisan Hemp Bill Introduced: New legislation aims to create a federal pathway and clear regulatory standards for hemp-derived cannabinoid products.
Top Stories
Procter & Gamble Acquires Thorne HealthTech for $3.8 Billion
Procter & Gamble has signed a definitive agreement to acquire supplement manufacturer Thorne HealthTech for $3.8 billion, purchasing the company from LVMH-backed private equity group L Catterton. The acquisition represents a 77% rate of return for the private equity firm and underscores P&G's significant bet on the growing personalized nutrition market. Thorne, which projects 2026 sales of $650 million, has successfully transitioned from a practitioner-focused brand to a major direct-to-consumer and retail powerhouse. The move aligns with a broader industry trend of multinational CPG companies expanding their footprints in the vitamins, minerals, and supplements category, joining P&G's existing portfolio that includes New Chapter and Metamucil. Read more
Kirin Holdings to Acquire Jamieson Wellness for C$2.5 Billion
Japan's Kirin Holdings has agreed to acquire Jamieson Wellness, Canada's leading supplement company, for C$2.5 billion (US$1.78 billion). The all-cash transaction will make the 104-year-old Toronto-based brand a wholly owned subsidiary of Kirin, establishing a critical North American platform for its Health Science business. Jamieson recently reported robust Q2 growth, with consolidated revenue increasing 17.4% to C$233.8 million, driven by a 21.7% increase in U.S. revenue and a 46.6% surge in China. The deal, expected to close in the fourth quarter of 2026, follows Kirin's recent acquisitions of Australian supplement firm Blackmores in 2023 and Japanese cosmetics brand FANCL in 2024. Read more
Bipartisan Hemp Bill Aims to Create Federal Pathway for Cannabinoid Products
Representatives Andy Barr and Angie Craig have introduced the Lawful Hemp Protection Act, directing the FDA to establish comprehensive standards for hemp-derived cannabinoid products. The legislation would mandate maximum cannabinoid content limits, labeling requirements, and good manufacturing practices while raising the legal definition of hemp from 0.3% to 1% total THC on a dry-weight basis. Crucially, if the FDA fails to complete rulemaking within one year, the bill establishes default statutory limits, including a fallback 5 mg THC serving limit for dietary supplements. This default limit has drawn criticism from industry groups like the Natural Products Association, though the bill aims to finally provide a clear regulatory framework for the sector. Read more
Business & Investment
Cascadia Advises Frontenac on NutriScience Acquisition
Cascadia Capital has advised private equity firm Frontenac on its acquisition of NutriScience Innovations, a Connecticut-based provider of specialty ingredients and solutions for the dietary supplement and functional food industries. The transaction highlights continued private equity interest in the nutraceutical supply chain, as investors seek to capitalize on the growing demand for specialized, science-backed ingredients. Read more
Robinson Pharma Opens 10th US Facility to Meet Contract Manufacturing Demand
Robinson Pharma has expanded its operations with the opening of a new 260,000-square-foot contract manufacturing facility in Irvine, California. As the company's tenth warehouse location, the expansion aims to increase production volume and operational efficiency across softgels, capsules, tablets, powders, and liquids. The investment reflects a broader industry trend of dietary supplement brands outsourcing manufacturing to scale quickly without heavy capital investments in proprietary infrastructure. Read more
Science & Research
Cargill's EpiCor Rapidly Modulates Immune Signaling at Gut Mucosa Level
A randomized, placebo-controlled crossover clinical trial involving 30 healthy adults demonstrated that a single 500 mg oral dose of Cargill's yeast-derived postbiotic, EpiCor, rapidly modulates immune signaling. The study found that EpiCor reduced levels of key inflammatory cytokines, including IFN-γ and IL-1ra, within one hour, followed by decreases in IL-4, IL-7, and IL-8 at two hours. Importantly, these changes occurred without broad immune suppression, suggesting a targeted modulation of immune responses initiated at the gut mucosa level. Read more
Hop Extract Study Shows Promise for Body Composition and Fat Loss
A 24-week placebo-controlled study of 150 adults found that participants taking Calocurb, a hop-derived nutraceutical, experienced significantly greater reductions in body weight (4.3% or 3.8 kg) and fat mass (4.5 kg) compared to the placebo group. The research, funded by Calocurb Ltd., utilized bioelectrical impedance analysis to confirm there was no indication of overall muscle loss. The findings support the activation of gastrointestinal bitter receptors as a promising non-pharmacological approach to improving body composition during weight loss. For individuals seeking metabolic support and energy balance, products like Vitamin B-Complex can be a valuable addition to a wellness routine. Read more
New Product Launches & Formulation
Ritual Expands Retail Reach to Costco with Essential Prenatal
Ritual has significantly expanded its retail distribution by launching its Essential Prenatal Multivitamin at all Costco warehouses nationwide. Club members can now purchase a two-month supply (120 capsules) for $48.99, marking a seven-fold increase in the brand's retail reach. Formulated with 12 key nutrients including omega-3 DHA, choline, and methylated folate, the product is backed by a human clinical trial published in Frontiers in Nutrition and utilizes a patented delayed-release capsule for optimal absorption. Read more
Precision Synbiotic Outperforms Probiotics for Toddler Gut Health
A 12-week trial involving 390 toddlers demonstrated that a precision synbiotic formulation combining probiotics with the prebiotic HMO 2'-fucosyllactose (2'-FL) provided broader protective effects than probiotics alone. The synbiotic group experienced lower rates of upper respiratory tract infections, pneumonia, diarrhea, and eczema. Researchers concluded that the specific combination enhanced intestinal immune homeostasis, paving the way for next-generation synbiotic formulations in early childhood nutrition. Read more
Monterey Nutra Doubles Capacity for US-Grown Mushroom Ingredients
Monterey Nutra has doubled its manufacturing capacity to meet the surging demand for US-grown functional mushroom ingredients. The expansion allows the company to process up to 1 million pounds of raw mushroom material annually. This operational scale-up highlights the increasing market emphasis on supply chain transparency and traceability from raw material cultivation to the finished botanical ingredient. For consumers seeking high-quality functional mushroom supplements, products like Lion's Mane offer targeted cognitive support. Read more
Regulations & Quality
Ryse Sued Over Alleged Protein Shortfalls in Clear Protein Drinks
A class-action lawsuit filed in California alleges that Ryse Up Sports Nutrition's Clear Protein Drinks contain significantly less protein than the 22g claimed on the label. Independent testing commissioned by the plaintiff found protein levels ranging from 19.69g to 20.69g per serving. The complaint argues the beverages qualify as "Class I" foods under FDA regulations and must contain at least the declared amount, highlighting a growing trend in protein-content litigation related to PDCAAS-adjusted calculations. Read more
South Korean Regulator Proposes Tighter GMP Controls for Customized Health Foods
South Korea's Ministry of Food and Drug Safety (MFDS) is proposing new measures to tighten GMP controls and labeling requirements for customized health functional foods. The proposed rules would require manufacturers to document all reprocessing procedures and verify that compressed air and lubricants do not compromise product quality. Additionally, the MFDS plans to mandate the printing of expiry dates on individual packs and the use of a record management system for in-house quality testing to prevent data falsification. Read more
Amazon Spain Blocks Listings Over RAP Number Compliance
Amazon Spain has initiated immediate blocks on dietary supplement listings and suspended seller accounts due to non-compliance with RAP (Registro de Actividades de Promoción) number requirements. This enforcement action underscores the growing regulatory scrutiny on e-commerce platforms regarding supplement sales in European markets, forcing sellers to ensure strict adherence to local compliance standards to avoid major business disruptions. Read more
Marketing & Consumer Trends
The Digestive Health Renaissance: Growing Demand for Gut Support
Digestive health is emerging as a foundational pillar in the supplement landscape, significantly influenced by the rise of GLP-1 medication use. According to NIQ data, GLP-1 users show a 68% higher rate of supplement usage and are 49% more likely to seek fiber-rich foods. This shift has driven sales of fiber in the natural enhanced channel up 8.9% to $2.38 million over a 52-week period, while probiotics and postbiotics continue to gain traction for their versatile, cross-functional health benefits. To support a healthy microbiome, a high-quality Multispore Probiotic can be highly beneficial. Read more
Polish Research Suggests Supplement Adverts Cause Consumer Confusion
A recent study published in the journal Nutrients found that consumer knowledge about dietary supplements in Poland remains poor, with only 4.8% correctly identifying them as food products and 40.3% mistakenly believing they are over-the-counter medicines. Consumers were most likely to believe marketing claims for immunity support and least likely to believe weight management claims. The findings emphasize the urgent need for improved consumer education and clearer labeling to prevent supplements from being confused with therapeutic drugs. Read more